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1. Introduction
  Mast cells play an important role in the mediation of 
inflammatory responses. Activated mast cells release 
pro-inflammatory cytokines such as tumor necrosis 
factor (TNF)-毩, interleukin (IL)-1毬, IL-6, IL-8, and 
inflammatory mediators including nitric oxide (NO), 
cyclooxygenase (COX)-2, and histamine[1-3]. The release 
of these cytokines and mediators participates in the 
development of variety of inflammatory reactions. Therefore, 
inhibition of mast cell activation is becoming a new 
therapeutic approach to control chronic inflammation.
  Activation of mast cells leads to phosphorylation of 
tyrosine kinase and mobilization of intracellular Ca2+. This 
is followed by activation of protein kinase C, mitogen-
activated protein kinase (MAPK), nuclear factor (NF)-
κB, and release of inflammatory cytokines[4-6]. MAPK 
signaling cascade plays an essential role in the initiation of 
inflammatory responses[7]. The induction of inflammatory 
cytokine genes requires activation of the MAPKs[8] and 
stimulation of extracellular regulated protein kinases/
mitogen-activated protein kinase (ERK/MAPK) pathways 
are essential for IL-8 production in human mast cell line 
(HMC)-1 cells[9]. 
  During the inflammatory processes, large amounts of 
mediators are released. Among these mediators, COX-2, a 
key enzyme for synthesizing prostaglandin, and inducible 
nitric oxide synthase (iNOS), a nitric oxide synthesis 
enzyme, have been implicated as mediators for variety of 
inflammatory reactions. NO exerted its inflammatory effects 
by stimulating iNOS and COX-2. Further activation of NO 
can initiate the transcription of downstream inflammatory 
genes such as pro-inflammatory cytokines (IL-1毬, 
TNF-毩, and IL-6), and following stimulation of enzyme 
mediators (COX-2 and iNOS) mediated by signaling 
intermediation of the MAPK pathways[10-12]. In recent 
years, it has been demonstrated that both COX-2 and iNOS 
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play important roles in various tumors and inflammatory 
diseases[10,13]. COX-2 and iNOS were also strongly induced 
in activated mast cells[14,15]. 
  Marine algae have begun to attract attention as rich sources 
of diverse bioactive compounds with great pharmaceutical 
and biomedical potential. Ecklonia cava (EC) is an abundant 
brown algae used in the south-west coastal region of 
Japan and Korea. It has been reported that EC extract have 
numerous biological activities, including anti-oxidative, 
radical scavenging, immunomodulatory, and anti-mutagenic 
activities[16-21]. Although several reports showed inhibitory 
effects of EC on inflammatory mediators from endothelial, 
microglial, and macrophage cells, the pharmacological 
actions of EC on pro-inflammatory cytokines and the 
underlying mechanisms in mast cells have not been 
investigated. In the present study, we examined the anti-
inflammatory effect of EC on phorbol 12-myristate 13-
acetate and calcium ionophore A23187 induced expression 
of pro-inflammatory cytokines and activation of MAPKs 
using human mast cell line, HMC-1.
2. Materials and methods
 2.1. Preparation of EC powder and extract
  EC was obtained from a local market in Seosan, Korea. 
Fresh EC was washed, dried in the shade, and ground 
into powder. The dried powder was extracted 3 times with 
10 volumes of ethanol at room temperature for 24 h. The 
combined extracts were centrifuged, filtered, concentrated 
under vacuum, lyophilized, and subsequently used for the 
experiment. The yield after vacuum evaporation was 14.2%.
2.2. Cell culture
  HMC-1 cells were grown in Iscove’s Modified Dulbecco’s 
medium (Gibco BRL, Grand Island, NY, USA) with 10% (v/v) 
FBS, 100 U/mL of penicillin, and 100 毺g/mL of streptomycin 
at 37 曟 in 5% (v/v) CO 2 atmosphere.  
2.3. Cytotoxicity
 Cell viability was assessed by the 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT, 
Sigma-Aldrich Inc., St. Louis, MO, USA) assay. Briefly, 
HMC-1 cells (1×105 cells/well) in 96 well plates with various 
concentrations (100-1 000 毺g/mL) of EC extract were 
incubated for 24 h, and MTT (5 mg/mL) was added and
further incubated for 4 h. The formazan crystals were 
dissolved in DMSO and the absorbance was measured at 
570 nm with microplate reader (Bio-Tek Instrument Inc., 
Winooski, VT, USA). 
2.4. Measurement of NO productions
  HMC-1 cells were treated with phorbol-12 myristate 13-
acetate (30 nmol/L) and A23187 (1 毺mol/L) (PMACI) in 
the presence of EC (0-100 毺g/mL) for 24 h in the 96 well 
plate. The concentration of NO in the culture supernatant 
was determined as nitrite, a major stable product of NO, 
using Griess reagent. Nitrite levels were determined 
colorimetrically at 540 nm. 
2.5. Determination of cytokines
  Release of the IL-1毬, TNF-毩, and IL-6 cytokines in 
PMACI stimulated HMC-1 cells was measured using a 
commercial BD CBA human inflammatory cytokine kit (BD 
Biosciences, Franklin Lakes, NJ, USA). Serum free HMC-1 
cells were treated with various doses of EC extract 
(0-100 毺g/mL) for 1 h before stimulation with PMACI and 
incubated for 8 h. After 3 h of incubation, samples were 
washed and analyzed using BD FACSTM flow cytometry (BD 
Biosciences). 
2.6. Real-time PCR (RT-PCR)
  Serum free HMC-1 cells were treated with EC extract for 
1 h before stimulation with PMACI and incubated for 8 h. 
Quantitative RT-PCR was used to quantify the expression 
of mRNAs for IL-1毬, TNF-毩 and IL-6. Total RNA was 
isolated using RNeasy kit (Qiagen, Valencia, CA, USA). 
First-strand cDNA was synthesized using 1 毺g of total RNA 
and SuperScript First-Strand cDNA synthesis kit (Invitrogen, 
Korea). Primers used for PCR-assisted amplification were as 
follows: 5’-ACC CCC AGG AGA AGA TTC CAA AG-3’ and 
5’-CAT GTC TCC TTT CTC AGG GCT GAG-3’ forward and 
reverse for IL-6, 5’-TTG ACC TCA GCG CTG AGT TG-3’ and 
5’-CCT GTA GCC CAC GTC GTA GC-3’ forward and reverse 
for TNF-毩, 5’-CAG GAT GAG GAC ATG AGC ACC-3’ 
and 5’-CTC TGC AGA CTC AAA CTC CAC-3’ forward and 
reverse for IL-1毬, and 5’-CAC TCA CGG CAA ATT CAA 
CGG CAC-3’ and 5’-GAC TCC ACG ACA TAC TCA GCA 
C-3’ forward and reverse for GAPDH. PCR amplification 
was carried out using SYBR RT-PCR kit (Takara, Japan). 
The PCR cycle was as follows: initial step at 95 曟 for
10 min followed by second step at 95 曟 for 30 s, 60 曟 for 
30 s for 40 cycles with melting curve analysis using Rotor 
Gene Q (Qiagen). The level of target mRNA was normalized 
to the level of GAPDH and compared with control (untreated 
sample) by ∆∆CT method[22] using Rotor Gene Q software 
version 1.7.  
2.7. Western blot analysis for iNOS, COX-2, and MAPK
  The levels of iNOS and COX-2 were determined in the 
cells which were stimulated with PMACI and pre-treated 
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with EC (0-100 毺g/mL). For analysis of activation of MAPK 
pathway, cells were pre-treated with EC (0-200 毺g/mL) 
for 30 min prior to stimulation with PMACI. Proteins were 
extracted with PRO-PREP Protein extraction solution (Intron 
biotechnology, Seongnam, Korea), and protein concentrations 
were measured using DC Protein assay kit (Bio-Rad, 
Hercules, CA, USA). Aliquots of samples were subjected to 
10% SDS-PAGE and transferred onto PVDF membrane. After 
blocking, the membrane was incubated with the appropriate 
primary antibody (Santa Cruz Biotechnology, CA, USA) 
followed by incubation with secondary antibody conjugated 
with horseradish peroxidase. Immunoreactive bands were 
visualized using chemiluminescent imaging system (Fusion 
SL2, Vilber Lourmat, Marne-la-Vallée Cedex, France), and 
analyzed by Bio1d software (Vilber Lourmat, France).
2.8. Statistical analysis
  Statistical analysis of the data obtained from all studies 
was implemented by the Statistical Package for the Social 
Sciences Software (SPSS, version 10.1 for windows, USA) and 
Student’s t-test. Data  expressed as mean依SD. P<0.05 was 
considered to indicate statistical significance.
3. Results
3.1. Effects on NO production
  PMACI significantly increased NO production to 1.95-
fold of the basal level in HMC-1 cells, and PMACI induced 
NO production was dose-dependently decreased by EC 
treatment (Figure 1). NO productions were decreased by 
25.4% and 46.6% at 50 and 100 毺g/mL EC treatments, 
respectively.
25
20
15
10
5
0
N
O
 p
ro
du
ct
io
n 
( 毺
m
ol
/L
)
EC (毺g/L) -                 0                  25                 50                100 
PMACI        -                    +                      +                      +                      +
*
#
#
Figure 1. Effect of EC on PMACI induced NO production in HMC-1 
cells.
Cells were treated with PMACI for 24 h in the presence of EC extract. 
Experiments were performed in triplicate using independent samples. 
Data are presented as mean依SD. *Significant difference with PMACI 
treatment (P<0.05). #Significant difference with EC treatment in the 
presence of PMACI (P<0.05).
  To exclude the possibility that the inhibition of NO 
production was due to cytotoxicity caused by EC treatment, 
MTT assays were performed in HMC-1 cells treated with EC 
extract. Cell viability was not significantly affected by EC 
up to 1 000 毺g/mL exhibiting 96.3%-89.9% cell viability 
at 50-1 000 毺g/mL over 24 h period (data not shown). 
Thus, the inhibitory effect of EC on PMACI stimulated NO 
production was not due to any cytotoxic action on HMC-1 
cells.
3.2. Effects on iNOS and COX-2 expression
 
  To determine the mechanism by which EC reduced PMACI 
induced NO production, the effects of EC on PMACI induced 
iNOS and COX-2 protein expressions were determined 
by western blot analysis. As shown in Figure 2, PMACI 
induced iNOS and COX-2 production was dose-dependently 
attenuated in HMC-1 cells pre-treated with EC.
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EC (毺g/L)     0                           25                         50                     100  
 
Figure 2.  Effect of Ecklonia cava (EC) on PMACI induced iNOS and 
COX-2 protein expression. 
Cells were pre-treated with EC prior to stimulation with PMACI, and 
expression of iNOS and COX-2 protein levels were determined by 
western blot. 毬-actin was used as an internal control. 
3.3. Effects on pro-inflammatory cytokine production and 
mRNA expression
  IL-1毬, TNF-毩, and IL-6 were known to be pro-
inflammatory cytokines that possessed a multitude of 
biological activities linked to the immune-pathology of 
acute or chronic inflammatory diseases. In order to assess 
the effect of EC on PMACI induced pro-inflammatory 
cytokine production, the HMC-1 cells were pre-treated with 
various concentrations of EC for 1 h prior to the addition of 
the stimulators. Figure 3A indicates that protein levels of 
IL-1毬, TNF-毩, and IL-6 were markedly up-regulated in 
response to PMACI stimulation. Pre-treatment of EC (4-100 
毺g/mL) significantly inhibited IL-1毬, TNF-毩, and IL-6 
productions in a dose-dependent manner. The effects of 
EC on IL-1毬 and TNF-毩 productions were greater than 
the effects on IL-6. The inhibitory effect of 100 毺g/mL EC 
on IL-1毬 and TNF-毩 production were 75.0% and 60.6%, 
respectively, while IL-6 production was reduced by 23.0%. 
  The PMACI stimulated IL-1毬, TNF-毩, and IL-6 mRNA 
expressions were also dose-dependently inhibited by EC, 
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and IL-1毬 mRNA expression was most affected by EC 
treatment (Figure 3B). IL-1毬 mRNA expression at 100 
毺g/mL EC treatment exhibited 6.2% of control value, while 
TNF-毩 and IL-6 mRNA expressions were 57.8% and 78.6% 
of control value, respectively.
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Figure 3.  Effect of Ecklonia cava (EC) on cytokine expression.
Cells were pre-treated with EC for 1 h before stimulation with PMACI. 
(A) Protein levels of IL-1毬, TNF-毩, and IL-6 were determined by 
ELISA. (B) The mRNA expression level of cytokines was determined 
by real-time PCR. Experiments were performed in triplicate using 
independent samples. Data are presented as mean依SD. *Significant 
difference with PMACI treatment (P<0.05). #Significant difference 
with EC treatment in the presence of PMACI (P<0.05).
3.4. Effects on MAPK activation
  MAPK signalling cascade plays an essential role in the 
cytokine production and inflammatory response. Therefore, 
in order to elucidate the mechanism underlying the effects 
of EC, activation of ERK1/2 was examined using western blot 
analysis (Figure 4). PMACI treatment significantly increased 
phosphorylated ERK1/2 expression to 4-fold of the control 
value, and EC pre-treatment significantly inhibited PMACI 
induced phosphorylation of ERK1/2 in a dose-dependent 
manner without affecting the total protein levels (Figure 4A, 
4B and 4E). The effect of EC on ERK1/2 activation was not 
significantly up to 50 毺g/mL concentration, and the ERK1/2 
activation was decreased by 18.4% and 35.5% at 100 and 
200 毺g/mL of EC concentration, respectively. Total ERK1/2 
protein expression levels were not affected by PMACI or EC 
treatment (Figure 4C and 4D). The results indicated that EC 
exerted its anti-inflammatory actions via inhibition of ERK/
MAPK signalling pathway.
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Figure 4. Effects of Ecklonia cava (EC) on activation of the ERK/
MAPK in HMC-1 cells. 
Phosphorylation of ERK1/2 was analyzed by western blot. (A and 
C) Western blot results of the phosphorylation of ERK1/2 and total 
ERK1/2.  (B, D and E) Densitometric results of the phosphorylation of 
ERK1/2. Data are presented as mean依SD. #Significant difference with 
EC treatment in the presence of PMACI (P<0.05).
4. Discussion
  Present study examined the pharmacological and biological 
effects of EC on the production of inflammatory mediators 
in human mast cells stimulated with PMACI. It has been 
reported that HMC-1 cells are immature cells unable 
to bind specific IgE due to a lack of FcεRI receptors[23]. 
Hence, we used PMACI as a substitute for the IgE/anti-IgE 
reaction in stimulating HMC-1 cells. To further understand 
the molecular mechanism of EC, the effects of EC on the 
production of NO, the expression levels of iNOS, COX-2, and 
cytokines (IL-1毬, TNF-毩, and IL-6), and the activation 
of ERK/MAPK were investigated. The results indicate that 
EC effectively inhibits PMACI induced pro-inflammatory 
cytokine and NO production through a blockade of the 
MAPK pathways in HMC-1 cells.
  During the inflammatory processes, large amounts of 
pro-inflammatory mediators, NO, and prostaglandin E2 is 
generated and suppression of these mediators may be a useful 
tool to reduce inflammatory symptoms[24]. The regulation 
of PMACI induced iNOS and COX-2 expression, which 
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is sensitive prime components of intracellular signalling 
pathways responsible for inflammatory events, by EC was 
elucidated using western blot analysis. In the present study, 
EC dose-dependently suppressed iNOS protein expression 
and subsequently it reduces COX-2 expression and NO 
content in PMACI stimulated HMC-1 cells. 
  Mast cell derived pro-inflammatory cytokines are 
important mediators of inflammation and have received 
much attention over the past decade. TNF-毩, IL-6, and 
IL-1 play a major role in triggering and sustaining the 
inflammatory response in mast cells[25], and the inhibition 
of these pro-inflammatory cytokine productions by mast 
cells may be a key to suppress the inflammatory symptoms. 
Recently Yang et al. reported that 6,6’-bieckol isolated 
from EC exhibited anti-inflammatory activity through the 
inhibition of TNF-毩 and IL-6 by negative regulation of the 
NFκB pathway in LPS-stimulated macrophages[20]. Also the 
inhibitory effect of EC extracts on the production of TNF-
毩 in LPS-induced human endothelial cells[21], and on the 
release of TNF-毩 and histamines mediated by IgE in murine 
asthma model[19] have been reported. IL-1毬 transcriptionally 
activates TNF-毩 and IL-13 mRNA, and protein production, 
and probably modulates TNF-毩 mediated inflammatory 
diseases[26,27]. As an initiator of inflammation, IL-1毬 
cooperates with arachidonic acid metabolites to recruit 
inflammatory immune cells, leading to the development of 
the adaptive immune response[26]. To gain further insights 
into the molecular mechanisms of EC-mediated inhibition 
of inflammatory mediators, the regulatory effects of EC on 
IL-1毬, TNF-毩, and IL-6 productions were evaluated. 
The results of the present study indicate that EC dose-
dependently inhibited the mRNA expression and production 
of IL-1毬, TNF-毩, and IL-6 in PMACI stimulated 
HMC-1 cells without any cytotoxic effect, suggesting its 
anti-inflammatory properties by regulating the cytokine 
production at the level of transcription. The inhibitory effect 
of IL-1毬 was greater than TNF-毩 and IL-6, suggesting 
that EC affects the initiation step of the inflammatory 
response. 
  The effect of EC was further investigated to determine 
whether EC has an inhibitory effect on signal transduction 
of mast cell stimulation. The MAPK cascade is one of the 
important signalling pathways in immune responses, and 
several recent studies reported that suppression of MAPKs in 
mast cells can be an appropriate target for pharmacological 
treatment of inflammatory disorder[7,28]. The MAPK pathway 
is also required for the expression of inflammatory mediator 
genes, including COX-2, iNOS, IL-1毬, and TNF-毩. It 
was reported that ERK and/or p38 MAPK are involved in 
up-regulation of IL-1毬 and IL-8 production[4,9], and p38 
MAPK inhibitor suppressed TNF-毩 and IL-6 production in 
monocytic or mast cells[6,8]. Inhibition of p38 MAPK and ERK 
also attenuated COX-2 activity[29]. In addition, ERK, p38, 
and JNK are known to participate in the pathway of iNOS 
expression[30]. The effect of EC on the activation of MAPK 
members in selected cell lines has also been reported. 
Dieckol isolated from EC inhibited LPS-induced activation 
of p38 MAPK pathway in microglial cells[31]. However, the 
regulation of MAPK signalling pathway in mast cells has 
not been reported. Therefore, the inhibitory effects of EC 
on the intracellular signalling network in pro-inflammatory 
cytokine expression by activation of MAPKs were examined 
in HMC-1 cells. EC dose-dependently blocked the 
activation of ERK1/2 induced by PMACI, suggesting that 
the anti-inflammatory effect of EC, at least in part, might 
be derived through regulation of the MAPK (ERK) pathway. 
Although EC attenuated ERK activation, the effects of EC 
on other pathway-involved MAPK and its upstream/down 
stream are not elucidated in the present study and remain to 
be clarified. 
  In conclusion, this study clearly demonstrated that 
EC exerts significant anti-inflammatory potential due 
to activated HMC-1 cells through the reduction of NO 
production by suppression of iNOS and COX-2 production 
as well as pro-inflammatory cytokines, including  IL-1毬 
and TNF-毩, at the transcriptional level. In addition, EC 
also inhibits the activation of the ERK/MAPK pathway. These 
results suggest that EC could contribute the prevention or 
treatment of mast cell-mediated inflammatory diseases.
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